Source: Basic and Clinical Pharmacology and Toxicology. Unidades: FORP, FMRP
Subjects: RECEPTORES ADRENÉRGICOS, PROTEÍNAS RECOMBINANTES, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAZ, Karina C. et al. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses. Basic and Clinical Pharmacology and Toxicology, v. 112, n. 2, p. 103-109, 2013Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12001. Acesso em: 05 nov. 2024.APA
Ferraz, K. C., Sousa-Santos, O., Neto-Neves, E. M., Rizzi, E., Muniz, J. J., Gerlach, R. F., & Tanus-Santos, J. E. (2013). Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses. Basic and Clinical Pharmacology and Toxicology, 112( 2), 103-109. doi:10.1111/bcpt.12001NLM
Ferraz KC, Sousa-Santos O, Neto-Neves EM, Rizzi E, Muniz JJ, Gerlach RF, Tanus-Santos JE. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses [Internet]. Basic and Clinical Pharmacology and Toxicology. 2013 ; 112( 2): 103-109.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bcpt.12001Vancouver
Ferraz KC, Sousa-Santos O, Neto-Neves EM, Rizzi E, Muniz JJ, Gerlach RF, Tanus-Santos JE. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses [Internet]. Basic and Clinical Pharmacology and Toxicology. 2013 ; 112( 2): 103-109.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bcpt.12001
